Expression of thymidine kinase mediated by a novel non-viral delivery system under the control of vascular endothelial growth factor receptor 2 promoter selectively kills human umbilical vein endothelial cells

World Journal of Gastroenterology

Volumn 14, Issue 2, 2008, Pages 224-230

  Wang, Ying ^a   Xu, Hui Xiong ^a   Lu, Ming De ^a   Tang, Qing ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

Gene therapy; Human umbilical vein endothelial cells; Microbubble; Ultrasound; Vascular endothelial growth factor receptor 2

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; ENHANCED GREEN FLUORESCENT PROTEIN; GANCICLOVIR; THYMIDINE KINASE; VASCULOTROPIN C;

ANTIANGIOGENIC GENE THERAPY; ARTICLE; CANCER GENE THERAPY; CELL STRAIN HEPG2; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG SELECTIVITY; DRUG SENSITIVITY; ECHOGRAPHY; ENDOTHELIUM CELL; GENE EXPRESSION; GENE TARGETING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MICROBUBBLE; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PROMOTER REGION; RECOMBINANT PLASMID; SUICIDE GENE; TUMOR CELL DESTRUCTION; UMBILICAL VEIN;

EID: 39849088295     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.14.224     Document Type: Article

References (27)